Suntrust Banks’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-13,747
Closed -$515K 1321
2018
Q2
$515K Sell
13,747
-2,799
-17% -$110K ﹤0.01% 910
2018
Q1
$650K Buy
+16,546
New +$604K ﹤0.01% 829
2016
Q2
Sell
-13,771
Closed -$261K 1550
2016
Q1
$261K Buy
+13,771
New +$249K ﹤0.01% 1197

Other funds holding XENT

Suntrust Banks's XENT Position: Q3 2018 in Review

Suntrust Banks sold out of Intersect ENT, Inc (XENT) in Q3 2018, closing a stake of 13,747 shares — an estimated $515K sold.

Suntrust Banks first reported a position in XENT in Q1 2016 and held it in 3 quarters. The position peaked at $650K in Q1 2018. 138 funds tracked by Wall St. Rank hold XENT as of Q3 2018.

  • Suntrust Banks reported no remaining Intersect ENT, Inc position as of Q3 2018 after selling out during the quarter.
  • Suntrust Banks sold 13,747 Intersect ENT, Inc shares in Q3 2018, an estimated $515K.
  • Suntrust Banks first reported a position in Intersect ENT, Inc in Q1 2016 and held it in 3 quarters.
  • Suntrust Banks's Intersect ENT, Inc position peaked at $650K in Q1 2018.
  • 138 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2018.

Based on Suntrust Banks's 13F filing for Q3 2018, filed 14 Nov 2018.